# Global Bio Fund

> Global Bio Fund is a VC fund backing Health Care and Therapeutics. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Total investments: 1
- Last investment: Mar 2022
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/global-bio-fund
- X (Twitter): https://twitter.com/GlobalBioFund
- Website: https://globalbiofund.org/
- Facebook: https://www.facebook.com/GlobalBioFund/

Global Bio Fund is a VC fund focused on Health Care and Therapeutics. Bio Innovation Impact. Building the world's first seed accelerator fund for women bio entrepreneurs #XCombinator

## Contacts

5 contacts available for Global Bio Fund. Shizune tracks 2 team members at Global Bio Fund. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/global-bio-fund?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 1 | 100% |
| Therapeutics | 1 | 100% |
| Biotechnology | 1 | 100% |
| Pharmaceutical | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Peder Nielsen | Member of the Global Advisors Network | 4 | https://shizune.co/investors/profile/peder-nielsen |
| Giorgio Reggiani | Founding Partner & CFO | 0 | https://shizune.co/investors/profile/giorgio-reggiani |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Geneos Therapeutics | Geneos is developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment. The company's technology is designed to identify relevant neoantigen targets from individual patient tumors to develop novel treatments for cancer, providing patients with tumor targeted immunotherapies to cure their disease. | $17M | Series A | Mar 24, 2022 |  |

1 of 1 investments shown.

## Co-investors
- [Flerie Invest](https://shizune.co/investors/profile/flerie-invest) — VC Fund, 1 deal together
- [Inovio Pharmaceuticals](https://shizune.co/investors/profile/inovio-pharmaceuticals) — VC Fund, 1 deal together
- [Korea Investment Partners](https://shizune.co/investors/profile/korea-investment-partners) — VC Fund, 1 deal together
- [Sante Ventures](https://shizune.co/investors/profile/sante-ventures) — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Global Bio Fund invest in?

Global Bio Fund invests primarily in Health Care, Therapeutics and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Global Bio Fund?

Public channels for Global Bio Fund include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Global Bio Fund?

The team at Global Bio Fund includes Peder Nielsen (Member of the Global Advisors Network) and Giorgio Reggiani (Founding Partner & CFO). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co